In the last 12 months, insiders at Viracta Therapeutics, Inc. ($VIRX) filed 33 transactions with the SEC: 0 open-market purchases totaling $0 and 1 sales totaling $2,493. Net insider sentiment: net selling.
Viracta Therapeutics, Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Chevallard Daniel R. (CFO and COO) — 4 transactions totaling $2,493
- Borellini Flavia (Not found) — 1 transaction totaling $0
- Rubino Stephen (Not found) — 1 transaction totaling $0
- Simon Barry J. (Not found) — 1 transaction totaling $0
- Chung Jane (Not found) — 1 transaction totaling $0
View all SEC Filings for Viracta Therapeutics, Inc. (VIRX).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov. 25, 2024 | ROYSTON IVOR | Not found | M | Common Stock | 25219 | $0.00 | 858,340.0000 | 39,744,222 | 3.03% | 0.06% |
| Nov. 25, 2024 | ROYSTON IVOR | Not found | M | Restricted Stock Units | 25219 | $0.00 | 50,438.0000 | 39,744,222 | 33.33% | 0.06% |
| Nov. 25, 2024 | Pomerantz Roger | Not found | M | Common Stock | 9034 | $0.00 | 126,478.0000 | 39,744,222 | 7.69% | 0.02% |
| Nov. 25, 2024 | Pomerantz Roger | Not found | M | Restricted Stock Units | 9034 | $0.00 | 18,069.0000 | 39,744,222 | 33.33% | 0.02% |
| Aug. 25, 2024 | ROYSTON IVOR | Not found | M | Common Stock | 25219 | $0.00 | 833,121.0000 | 39,272,434 | 3.12% | 0.06% |
| Aug. 25, 2024 | ROYSTON IVOR | Not found | M | Restricted Stock Units | 25219 | $0.00 | 75,657.0000 | 39,272,434 | 25.00% | 0.06% |
| Aug. 25, 2024 | Pomerantz Roger | Not found | M | Common Stock | 9034 | $0.00 | 117,444.0000 | 39,272,434 | 8.33% | 0.02% |
| Aug. 25, 2024 | Pomerantz Roger | Not found | M | Restricted Stock Units | 9034 | $0.00 | 27,103.0000 | 39,272,434 | 25.00% | 0.02% |
| June 20, 2024 | ROYSTON IVOR | Not found | A | Stock Option (Right to Buy) | 50000 | $0.00 | 50,000.0000 | 39,272,434 | 9999.99% | 0.13% |
| June 20, 2024 | Borellini Flavia | Not found | A | Stock Option (Right to Buy) | 50000 | $0.00 | 50,000.0000 | 39,272,434 | 9999.99% | 0.13% |
| June 20, 2024 | Chung Jane | Not found | A | Stock Option (Right to Buy) | 50000 | $0.00 | 50,000.0000 | 39,272,434 | 9999.99% | 0.13% |
| June 20, 2024 | Murphy Samuel Lafayette | Not found | A | Stock Option (Right to Buy) | 50000 | $0.00 | 50,000.0000 | 39,272,434 | 9999.99% | 0.13% |
| June 20, 2024 | DARCY THOMAS E | Not found | A | Stock Option (Right to Buy) | 50000 | $0.00 | 50,000.0000 | 39,272,434 | 9999.99% | 0.13% |
| June 20, 2024 | Simon Barry J. | Not found | A | Stock Option (Right to Buy) | 50000 | $0.00 | 50,000.0000 | 39,272,434 | 9999.99% | 0.13% |
| June 20, 2024 | Barlow Jane F | Not found | A | Stock Option (Right to Buy) | 50000 | $0.00 | 50,000.0000 | 39,272,434 | 9999.99% | 0.13% |
| June 20, 2024 | Pomerantz Roger | Not found | A | Stock Option (Right to Buy) | 50000 | $0.00 | 50,000.0000 | 39,272,434 | 9999.99% | 0.13% |
| June 20, 2024 | Pomerantz Roger | Not found | A | Stock Option (Right to Buy) | 18750 | $0.00 | 18,750.0000 | 39,272,434 | 9999.99% | 0.05% |
| June 20, 2024 | Rubino Stephen | Not found | A | Stock Option (Right to Buy) | 50000 | $0.00 | 50,000.0000 | 39,272,434 | 9999.99% | 0.13% |
| May 25, 2024 | Pomerantz Roger | Not found | M | Common Stock | 9035 | $0.00 | 108,410.0000 | 39,272,434 | 9.09% | 0.02% |
| May 25, 2024 | Pomerantz Roger | Not found | M | Restricted Stock Units | 9035 | $0.00 | 36,137.0000 | 39,272,434 | 20.00% | 0.02% |
| May 25, 2024 | ROYSTON IVOR | Not found | M | Common Stock | 25219 | $0.00 | 807,902.0000 | 39,272,434 | 3.22% | 0.06% |
| May 25, 2024 | ROYSTON IVOR | Not found | M | Restricted Stock Units | 25219 | $0.00 | 100,876.0000 | 39,272,434 | 20.00% | 0.06% |
| May 14, 2024 | Faerm Michael E. | Chief Financial Officer | A | Stock Option (Right to Buy) | 500000 | $0.00 | 500,000.0000 | 39,272,434 | 9999.99% | 1.27% |
| March 12, 2024 | Rothera Mark | President and CEO | A | Stock Option (Right to Buy) | 475000 | $0.00 | 475,000.0000 | 39,272,434 | 9999.99% | 1.21% |
| March 12, 2024 | Cohen Darrel P. | Chief Medical Officer | A | Stock Option (Right to Buy) | 120000 | $0.00 | 120,000.0000 | 39,272,434 | 9999.99% | 0.31% |
| March 12, 2024 | Chevallard Daniel R. | CFO and COO | A | Stock Option (Right to Buy) | 200000 | $0.00 | 200,000.0000 | 39,272,434 | 9999.99% | 0.51% |
| Feb. 25, 2024 | ROYSTON IVOR | Director | M | Common Stock | 25219 | $0.00 | 782,683.0000 | 0 | 3.33% | 0.00% |
| Feb. 25, 2024 | ROYSTON IVOR | Director | M | Restricted Stock Units | 25219 | $0.00 | 126,095.0000 | 0 | 16.67% | 0.00% |
| Feb. 25, 2024 | Pomerantz Roger | Director | M | Common Stock | 9034 | $0.00 | 99,375.0000 | 0 | 10.00% | 0.00% |
| Feb. 25, 2024 | Pomerantz Roger | Director | M | Restricted Stock Units | 9034 | $0.00 | 45,172.0000 | 0 | 16.67% | 0.00% |
| Feb. 25, 2024 | Chevallard Daniel R. | CFO and COO | M | Common Stock | 6889 | $0.00 | 105,711.0000 | 0 | 6.97% | 0.00% |
| Feb. 27, 2024 | Chevallard Daniel R. | CFO and COO | S | Common Stock | 3405 | $0.73 | 102,306.0000 | 0 | 3.22% | 0.00% |
| Feb. 25, 2024 | Chevallard Daniel R. | CFO and COO | M | Restricted Stock Units | 6889 | $0.00 | 34,444.0000 | 0 | 16.67% | 0.00% |